Biotech

All Articles

Takeda takes $140M reduction on fallen short epilepsy medication, promotes FDA run

.Our company currently recognize that Takeda is actually expecting to locate a path to the FDA for e...

VBI Injections files for personal bankruptcy, looks for property sale

.Immunology biotech VBI Vaccines is actually turning precariously close to the climax, with plans to...

Celldex anti-cKIT antitoxin minimize hives in another phase 2 study

.It is actually hard to muscle mass in on an area as competitive as immunology, however Celldex Ther...

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Rehabs and also a preclinical immune ...

Ventyx's last hope for inflammatory med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's illness medicine performed not assist patients achieve remission in a p...

Cognition's period 2 sparkle information stain Alzheimer's possibility

.Knowledge Therapies' phase 2 luster test has taken several of the gloss off the Alzheimer's health ...

BMS axes bispecific months after submitting to run stage 3 trial

.Bristol Myers Squibb has had a whiplash change of heart on its own BCMA bispecific T-cell engager, ...

Charles Baum consumes Terremoto as CEO

.Charles Baum, M.D., Ph.D., that oversaw Mirati Therapies' $ 5.8 billion purchase to Bristol Myers S...

Asarina to shut after attempts to companion Tourette's medication neglect

.After reaching out to much more than 200 providers to companion a Tourette syndrome therapy that re...

Novartis pens $150M in advance bispecifics cope with Dren Bio

.Novartis has actually had some bad luck along with bispecific antibodies previously, however determ...